Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Trial of the Carboplatin/Gemcitabine Combination as First Line Treatment for Elderly Patients With Stage IV NSCLC.

NCT02175381 is registered in ClinicalTrials.gov with Hellenic Oncology Research Group as lead sponsor.

NCT NCT02175381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02175381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Trial of the Carboplatin/Gemcitabine Combination as First Line Treatment for Elderly Patients With Stage IV NSCLC.
Lead sponsor
Hellenic Oncology Research Group
Phase
Phase 1/2
Overall status
Completed
Start date
February 28, 2011
Completion date
April 30, 2014
Enrollment
69 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc